Search

Learn what you need to know about safety requirements for breast implants.

… Thursday, September 15, 2022 The U.S. Food and Drug Administration (FDA) reported on September 8 that a small number of cases of squamous cell carcinoma (SCC) had been found in the scar tissue of women with breast implants. The FDA is aware of fewer than 20 of these cases of SCC. While the finding appears

Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.

… Thursday, January 28, 2021 On January 28, 2021, Memorial Sloan Kettering (MSK) and more than 75 national cancer centers and organizations endorsed an open letter from the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) urging Americans to resume regular cancer screenings

Read highlights of research presented by MSK scientists at the annual ASH meeting.

… Monday, December 9, 2024 Research advances in lymphoma, leukemia, and multiple myeloma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the  American Society of Hematology (ASH) Annual Meeting , which runs December 7–10. Below are some highlights. Dual-Targeting of JAK

A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.

… Saturday, May 30, 2009 A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don’t require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan Kettering Cancer Center (MSKCC) presented

Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.

… Friday, April 5, 2019 Summary TGF-ß, which has been studied for more than 30 years, has many jobs. One of them is helping to regulate the immune system. The immunotherapy drugs called checkpoint inhibitors have transformed treatment for some people with cancer. Currently, a major focus in cancer research

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for August 2022.

… Tuesday, August 23, 2022 Valerie Rusch, MD, FACS Valerie Rusch, MD, FACS Valerie Rusch Receives the 2022 Adi F. Gazdar International Association for the Study of Lung Cancer Merit Award Valerie Rusch, MD, FACS , Vice Chair for Clinical Research, Department of Surgery, was awarded the 2022 Adi F. Gazdar

Encouraging clinical trial data from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program and presented as part of the Precision Medicine Early Clinical Trial Plenary Session.

… Sunday, April 17, 2016 Encouraging clinical trial data from Memorial Sloan Kettering Cancer Center (MSK) will be featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program and presented as part of the Precision Medicine Early Clinical Trial Plenary Session. Alexander

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

… Wednesday, November 19, 2014 A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.  MSK was at the forefront

Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic.

… Tuesday, November 26, 2013 Summary Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic. More than 25 million people in the United States have been diagnosed with diabetes

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.

… Thursday, September 25, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately